Ligand validation:4I91

CM5: 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE

CM5 is a Ligand Of Interest in 4I91 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4I91_CM5_A_503	40%	73%	0.101	0.927	0.47	0.56	-	-	0	0	35%	0.3529
4I91_CM5_A_505	3%	70%	0.243	0.702	0.49	0.66	-	-	0	0	35%	0.3529
4I91_CM5_A_504	1%	1%	0.337	0.519	3.41	4.71	15	21	1	0	100%	1
5UAP_CM5_B_503	57%	18%	0.156	0.932	1.16	2.33	2	10	2	0	100%	1
5UFG_CM5_A_503	32%	2%	0.166	0.839	3.3	3.62	10	25	0	0	100%	1
3QU8_CM5_D_604	31%	0%	0.211	0.878	4.17	6.24	16	24	0	1	100%	1
5UDA_CM5_B_503	24%	62%	0.163	0.909	0.57	0.88	-	-	1	0	35%	0.3529
4RRT_CM5_A_503	21%	72%	0.178	0.905	0.28	0.78	-	-	1	0	35%	0.3529
4LLH_CM5_C_602	33%	29%	0.271	0.954	1.48	1.35	6	6	1	4	100%	1
5KKE_CM5_A_204	31%	46%	0.17	0.835	1.07	1.01	2	1	0	0	100%	0.45

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.